Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sana Biotechnology
Research
Sana's engineered islet cells control glucose in diabetic monkey
The transplanted islet cells controlled the animal's glucose levels for six months without the need for insulin or immunosuppression.
Helen Floersh
Feb 15, 2024 2:55pm
Sana retreats from in vivo CAR-T delivery, lays off 29% of staff
Oct 11, 2023 5:00am
Sana tight-lipped on extent of latest round of layoffs
Sep 1, 2023 5:40am
Sana lays off 15%, trims pipeline to keep funding CAR-Ts
Nov 30, 2022 8:43am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Biotech IPOs in the current market environment 'a bit silly'
Feb 22, 2022 3:00am